Recent Posts
- MicroRNA-Mediated Metastasis Suppression
- A New Explanation Of ‘Asian Paradox’
- Toward Bold New Anti-cancer Medicines
- Celsion And Yakult Honsha Announce Treatment Of First Patient In Japan In Celsion’s Global Phase III ThermoDox(R) Trial For Primary Liver Cancer
- $6.5 Million Gift To UCSF From Irwin And Joan Jacobs For Head And Neck Cancer Research
Random Posts
- Previous Results Should Influence Colonoscopy Intervals (CME/CE, with audio)
- Diagnostic Evaluation Of PSA Recurrence And Review Of Hormonal Management After Radical Prostatectomy
- Toward New Drugs That Turn Genes On And Off
- FDA Approves Drug For Treatment Of Aggressive Brain Cancer
- Public Want Ban On Sunbeds For Under 18s, UK
- Thyroid Cancer Increasing, Scientists Don't Know Why
- ASCO: Trial May End Survival Advantage as Sign of Potency
- Cetuximab Prolongs Survival in Non-Small-Cell Lung Cancer
- Emory Named To Nationwide NCI Chemical Biology Consortium By National Cancer Institute
- Retroperitoneal Lymphadenectomy Vs. 1 Cycle BEP As Adjuvant Therapy For Non-Seminomatous Testicular Tumours In Clinical Stage I
Prescription Cancer Drugs
AUA: Dutasteride Works Against Prostate Cancer
Posted by: admin in Cancer Treatment, Prescription Cancer Drugs on May 04th, 2009
CHICAGO, April 29 — Prostate cancer incidence decreased by 23% in high-risk men treated with dutasteride (Avodart), according to results of an international clinical trial.
Action Points